| Literature DB >> 33029562 |
Gregorio González-Alcaide1, Pedro Llorente2,3, José-Manuel Ramos-Rincón4,5.
Abstract
INTRODUCTION: Population surveillance provides data on the health status of the population through continuous scrutiny of different indicators. Identifying risk factors is essential for the quickly detecting and controlling of epidemic outbreaks and reducing the incidence of cross-infections and non-communicable diseases. The objective of the present study is to analyze research on population surveillance, identifying the main topics of interest for investigators in the area.Entities:
Keywords: Bibliometrics; Content analysis; Data mining; Disease outbreaks; Information science; Knowledge representation; Network analysis; Public health; Public health surveillance; Research gaps; Subject areas
Year: 2020 PMID: 33029562 PMCID: PMC7528878 DOI: 10.1016/j.heliyon.2020.e05141
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Description of the Medical Subject Headings (MeSH) included in the search strategy.
| MeSH term | Description |
|---|---|
| Population surveillance (year introduced: 1967) | Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy. |
| Public Health surveillance (Year introduced: 2013, use Population Surveillance 1990–2012) | The ongoing, systematic collection, analysis, and interpretation of health-related data for the purpose of preventing or controlling disease or injury, or of identifying unusual events of public health importance, followed by the dissemination and use of information for public health action. (From |
| Sentinel surveillance (year introduced: 1995) | Monitoring the rate of occurrence of specific conditions to assess the stability or change in health levels of a population. It is also the study of disease rates in a specific cohort such as in a geographic area or population subgroup to estimate trends in a larger population. (From Last, |
| Biosurveillance (year introduced: 2009) | Monitoring of information sources of potential value in detecting an emerging epidemic, whether naturally occurring or the result of bioterrorism. |
MeSH terms linked to coronavirus and included in the search strategy that generated the coronavirus network linked to population surveillance (descriptors assigned to at least one document are in cursive).
| Coronaviridae |
| Coronavirus |
| Alphacoronavirus |
| Alphacoronavirus 1 |
| Coronavirus, Canine |
| Coronavirus, Feline |
| Transmissible gastroenteritis virus |
| Porcine Respiratory Coronavirus |
| Coronavirus 229E, Human |
| Coronavirus NL63, Human |
| Porcine epidemic diarrhea virus |
| Betacoronavirus |
| Betacoronavirus 1 |
| Coronavirus OC43, Human |
| Coronavirus, Bovine |
| Coronavirus, Rat |
| Middle East Respiratory Syndrome Coronavirus |
| Murine hepatitis virus |
| SARS Virus |
| Gammacoronavirus |
| Coronavirus, Turkey |
| Infectious bronchitis virus |
| Coronaviridae Infections |
| Coronavirus Infections |
| Enteritis, Transmissible, of Turkeys |
| Feline Infectious Peritonitis |
| Gastroenteritis, Transmissible, of Swine |
| Severe Acute Respiratory Syndrome |
Figure 1Evolution in the number of documents on population surveillance (2000–2017∗) and retrieved from the Web of Science Core Collection databases. ∗The documents published in 2018 (n = 2578) and 2019 (n = 1160) were not included in the figure due to the delay in the assignment of descriptors and in the updating of the databases; thus for these years, data were incomplete at the time of the bibliographic search.
Distribution of the number of documents on population surveillance (2000–2019) by thematic category.
| Web of Science subject category | N docs | % | N journals | N docs/journal |
|---|---|---|---|---|
| Public, Environmental & Occupational Health | 8473.28 | 21.62 | 277 | 30.59 |
| Infectious Diseases | 4111.17 | 10.49 | 104 | 39.53 |
| Medicine, General & Internal | 2584.92 | 6.60 | 163 | 15.86 |
| Oncology | 1778.55 | 4.54 | 142 | 12.52 |
| Multidisciplinary Sciences | 1672.33 | 4.27 | 28 | 59.73 |
| Immunology | 1460.45 | 3.73 | 99 | 14.75 |
| Veterinary Sciences | 1440.35 | 3.68 | 84 | 17.15 |
| Pediatrics | 1019.67 | 2.60 | 109 | 9.35 |
| Cardiac & Cardiovascular Systems | 916.08 | 2.34 | 101 | 9.07 |
| Gastroenterology & Hepatology | 821.83 | 2.10 | 75 | 10.96 |
| Microbiology | 818.95 | 2.09 | 74 | 11.07 |
| Psychiatry | 777.55 | 1.98 | 130 | 5.98 |
| Clinical Neurology | 626.20 | 1.60 | 118 | 5.31 |
| Surgery | 591.50 | 1.51 | 143 | 4.14 |
| Health Care Sciences & Services | 581.03 | 1.48 | 127 | 4.57 |
| Urology & Nephrology | 545.67 | 1.39 | 66 | 8.27 |
| Tropical Medicine | 516.70 | 1.32 | 26 | 19.87 |
| Obstetrics & Gynecology | 441.25 | 1.13 | 74 | 5.96 |
| Pharmacology & Pharmacy | 427.00 | 1.09 | 109 | 3.92 |
| Medicine, Research & Experimental | 397.47 | 1.01 | 74 | 5.37 |
Top 15 most productive journals in population surveillance (2000–2019).
| Top 15 journals | N docs | % | Impact factor | Journal category (ranking within subject category) |
|---|---|---|---|---|
| PLOS ONE | 1275 | 3.25 | 2.776 | Multidisciplinary Sciences (24/69) |
| Emerging Infectious Diseases | 1032 | 2.63 | 7.185 | Immunology (23/158) |
| BMC Public Health | 531 | 1.36 | 2.567 | Public, Environmental & Occupational Health (59/186) |
| Infection Control and Hospital Epidemiology | 487 | 1.24 | 2.856 | Infectious Diseases (41/89) |
| Vaccine | 411 | 1.05 | 3.269 | Medicine, Research & Experimental (57/136) |
| American Journal of Public Health | 388 | 0.99 | 5.381 | Public, Environmental & Occupational Health (12/186) |
| Epidemiology and Infection | 367 | 0.94 | 2.047 | Infectious Diseases (66/89) |
| Clinical Infectious Diseases | 318 | 0.81 | 9.055 | Immunology (11/151) |
| American Journal of Epidemiology | 304 | 0.78 | 4.4.73 | Public, Environmental & Occupational Health (20/186) |
| Eurosurveillance | 300 | 0.77 | 7.421 | Infectious Diseases (4/89) |
| Communicable Diseases Intelligence | 293 | 0.75 | - | |
| Scientific Reports | 287 | 0.73 | 4.011 | Multidisciplinary Sciences (15/69) |
| Journal of Infectious Diseases | 286 | 0.73 | 5.049 | Immunology (33/151) |
| International Journal of Cardiology | 275 | 0.70 | 3.471 | Cardiology & Cardiovascular systems (48/136) |
| Public Health Reports | 274 | 0.70 | 2.039 | Public, Environmental & Occupational Health (86/186) |
Number of documents on population surveillance, by region and five-year period (2000–2019).
| Geographic area | 2000–2004 | 2005–2009 | 2010–2014 | 2015–2019 | TOTAL | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | N | % | N | % | |
| North America | 3012 | 41.93 | 4,037 | 37.51 | 5377 | 36.12 | 5224 | 33.40 | 17,650 | 36.41 |
| Europe | 2509 | 34.93 | 3,711 | 34.48 | 4672 | 31.38 | 4665 | 29.83 | 15,557 | 32.09 |
| Asia | 706 | 9.83 | 1,277 | 11.86 | 2285 | 15.35 | 3038 | 19.42 | 7306 | 15.07 |
| Oceania | 396 | 5.51 | 738 | 6.86 | 1001 | 6.72 | 1026 | 6.56 | 3161 | 6.52 |
| Africa | 341 | 4.75 | 510 | 4.74 | 859 | 5.77 | 986 | 6.30 | 2696 | 5.56 |
| Latin America & Caribbean | 219 | 3.05 | 490 | 4.55 | 694 | 4.66 | 702 | 4.49 | 2105 | 4.34 |
| TOTAL | 7,183 | 100 | 10,763 | 100 | 14,888 | 100 | 15,641 | 100 | 48,475 | 100 |
Documents on population surveillance by the top 15 most productive countries (2000–2019).
| 2000–2004 | 2005–2009 | 2010–2014 | 2015–2019 | Total (2000–2019) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Country | N | % | Country | N | % | Country | N | % | Country | N | % | Country | N | % |
| USA | 2752 | 43.84 | USA | 3572 | 39.84 | USA | 4743 | 39.55 | USA | 4660 | 39 | USA | 15727 | 40.14 |
| UK | 765 | 12.19 | UK | 1059 | 11.81 | UK | 1382 | 11.52 | UK | 1473 | 12.33 | UK | 4679 | 11.94 |
| Australia | 354 | 5.64 | Australia | 636 | 7.09 | Australia | 867 | 7.23 | China | 941 | 7.87 | Australia | 2797 | 7.14 |
| France | 339 | 5.4 | Canada | 618 | 6.89 | Canada | 848 | 7.07 | Australia | 940 | 7.87 | Canada | 2603 | 6.64 |
| Canada | 325 | 5.18 | Germany | 504 | 5.62 | Germany | 636 | 5.3 | Canada | 812 | 6.79 | France | 2097 | 5.35 |
| Germany | 294 | 4.68 | France | 479 | 5.34 | France | 606 | 5.05 | France | 673 | 5.63 | Germany | 2058 | 5.25 |
| Sweden | 260 | 4.14 | Netherlands | 390 | 4.35 | China | 572 | 4.77 | Sweden | 672 | 5.62 | China | 1861 | 4.75 |
| Netherlands | 243 | 3.87 | Italy | 348 | 3.88 | Netherlands | 550 | 4.59 | Germany | 624 | 5.22 | Sweden | 1781 | 4.55 |
| Italy | 214 | 3.41 | Sweden | 333 | 3.71 | Sweden | 516 | 4.3 | Netherlands | 584 | 4.89 | Netherlands | 1767 | 4.51 |
| Denmark | 165 | 2.63 | Switzerland | 307 | 3.42 | Italy | 500 | 4.17 | Italy | 505 | 4.23 | Italy | 1567 | 4 |
| Switzerland | 161 | 2.56 | Brazil | 258 | 2.88 | Spain | 390 | 3.25 | Spain | 417 | 3.49 | Switzerland | 1251 | 3.19 |
| Spain | 155 | 2.47 | Japan | 255 | 2.84 | Switzerland | 377 | 3.14 | Switzerland | 406 | 3.4 | Spain | 1182 | 3.02 |
| Japan | 146 | 2.33 | China | 233 | 2.6 | Brazil | 353 | 2.94 | Brazil | 372 | 3.11 | Brazil | 1078 | 2.75 |
| Finland | 141 | 2.25 | Spain | 220 | 2.45 | Japan | 298 | 2.48 | Japan | 367 | 3.07 | Japan | 1066 | 2.72 |
| Norway | 130 | 2.07 | Denmark | 215 | 2.4 | Taiwan | 292 | 2.43 | Denmark | 356 | 2.98 | Denmark | 1016 | 2.59 |
Figure 2Main topic clusters linked to research on population surveillance. Each color represents a different cluster; the size of the nodes is proportional to the number of documents that have been assigned the descriptor, and the thickness of the ties reflects the intensity of the co-occurrence between linked descriptors.
Top descriptors related to diseases (>1% of the documents) in scientific output on population surveillance (2000–2019).
| MeSH descriptors | 2000–2004 (N = 6277) | 2005–2009 (N = 8965) | 2010–2014 (N = 11,992) | 2015–2019 (N = 11,950) | Total (N = 39,184) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | n | % | n | % | ||
| HIV Infections | 283 | 4.51 | 415 | 4.63 | 595 | 4.96 | 584 | 4.89 | 1877 | 4.79 |
| Influenza, Human | 91 | 1.45 | 283 | 3.16 | 685 | 5.71 | 561 | 4.69 | 1620 | 4.13 |
| Cross Infection | 285 | 4.54 | 464 | 5.18 | 361 | 3.01 | 208 | 1.74 | 1318 | 3.36 |
| Breast Neoplasms | 128 | 2.04 | 159 | 1.77 | 167 | 1.39 | 367 | 3.07 | 821 | 2.10 |
| Neoplasms | 115 | 1.83 | 161 | 1.80 | 227 | 1.89 | 280 | 2.34 | 783 | 2.00 |
| Obesity | 102 | 1.62 | 224 | 2.50 | 259 | 2.16 | 196 | 1.64 | 781 | 1.99 |
| Cardiovascular Diseases | 75 | 1.19 | 163 | 1.82 | 270 | 2.25 | 251 | 2.10 | 759 | 1.94 |
| Neoplasm Staging | 69 | 1.10 | 115 | 1.28 | 176 | 1.47 | 378 | 3.16 | 738 | 1.88 |
| Wounds and Injuries | 126 | 2.01 | 172 | 1.92 | 195 | 1.63 | 144 | 1.21 | 637 | 1.63 |
| Communicable Diseases | 96 | 1.53 | 146 | 1.63 | 195 | 1.63 | 183 | 1.53 | 620 | 1.58 |
| Colorectal Neoplasms | 79 | 1.26 | 126 | 1.41 | 166 | 1.38 | 206 | 1.72 | 577 | 1.47 |
| Chronic Disease | 87 | 1.39 | 147 | 1.64 | 177 | 1.48 | 139 | 1.16 | 550 | 1.40 |
| Tuberculosis | 81 | 1.29 | 106 | 1.18 | 142 | 1.18 | 167 | 1.40 | 496 | 1.27 |
| Hypertension | 81 | 1.29 | 130 | 1.45 | 148 | 1.23 | 134 | 1.12 | 493 | 1.26 |
| Occupational Diseases | 125 | 1.99 | 102 | 1.14 | 149 | 1.24 | 77 | 0.64 | 453 | 1.16 |
| Stroke | 59 | 0.94 | 84 | 0.94 | 154 | 1.28 | 132 | 1.10 | 429 | 1.09 |
| Staphylococcal Infections | 88 | 1.40 | 142 | 1.58 | 128 | 1.07 | 68 | 0.57 | 426 | 1.09 |
| Prostatic Neoplasms | 23 | 0.37 | 82 | 0.91 | 162 | 1.35 | 153 | 1.28 | 420 | 1.07 |
| Respiratory Tract Infections | 99 | 1.58 | 83 | 0.93 | 98 | 0.82 | 135 | 1.13 | 415 | 1.06 |
| Streptococcus pneumoniae | 112 | 1.78 | 116 | 1.29 | 91 | 0.76 | 95 | 0.79 | 414 | 1.06 |
| Communicable Diseases, Emerging | 43 | 0.69 | 125 | 1.39 | 111 | 0.93 | 121 | 1.01 | 400 | 1.02 |
| Zoonoses | 32 | 0.51 | 125 | 1.39 | 148 | 1.23 | 94 | 0.79 | 399 | 1.02 |
| Pneumococcal Infections | 98 | 1.56 | 104 | 1.16 | 102 | 0.85 | 92 | 0.77 | 396 | 1.01 |
Figure 3Network of MeSH descriptors linked to publications on coronavirus in the literature on population surveillance.
Bibliometric indicators on scientific output, collaboration, and citation in the clusters under the area of population surveillance.
| Cluster | N docs | Authors' collab. index | ±SD | Int. collab. (% docs) | N citations | Citations/doc | ±SD | |
|---|---|---|---|---|---|---|---|---|
| Disease outbreaks | 5493 | 6.52 | ±5.05 | 32.28 | 139923 | 25.47 | ±74.49 | 137 |
| Cross infections | 3875 | 7.05 | ±6.91 | 22.069 | 144490 | 37.29 | ±114.71 | 143 |
| Neoplasms | 3265 | 7.08 | ±5.54 | 21.911 | 114099 | 34.95 | ±136.08 | 136 |
| Influenza | 2899 | 7.8 | ±7.15 | 31.772 | 74007 | 25.53 | ±71.82 | 105 |
| HIV | 2869 | 6.64 | ±4.82 | 34.586 | 78998 | 27.53 | ±61.19 | 113 |
| Pregnancy | 2462 | 6.4 | ±5.84 | 29.192 | 65900 | 26.77 | ±64.73 | 104 |
| Substance abuse/obesity | 2338 | 5.67 | ±4.39 | 22.938 | 91561 | 39.16 | ±112.56 | 127 |
| Genetics | 2148 | 9.17 | ±6.97 | 36.852 | 63352 | 29.49 | ±76.02 | 103 |
| Cardiovascular and coronary diseases | 1113 | 6.84 | ±4.55 | 25.361 | 38614 | 34.69 | ±69.04 | 93 |
| Mental diseases | 795 | 5.45 | ±3.41 | 23.232 | 38474 | 48.39 | ±110.11 | 93 |
| Diabetes | 687 | 6.95 | ±16.81 | 22.076 | 21480 | 31.27 | ±58.18 | 73 |
| Tuberculosis | 685 | 6.74 | ±4.72 | 36.873 | 17406 | 25.41 | ±63.73 | 58 |
| Wounds and injuries | 637 | 4.94 | ±6.55 | 25.832 | 17255 | 27.09 | ±92.87 | 55 |
| Stroke | 429 | 6.72 | ±3.76 | 25.472 | 19802 | 46.16 | ±189.85 | 63 |
| Asthma | 370 | 6.94 | ±11.5 | 24.59 | 12290 | 33.22 | ±53.92 | 57 |
| Coronavirus | 143 | 6.99 | ±6.33 | 35.252 | 2888 | 20.19 | ±35.12 | 29 |
These diseases are specific areas of the cluster “General concepts around public health and specific diseases”.
Top 20 descriptors related to public health in the scientific output on population surveillance (2000–2019).
| MeSH descriptors | 2000–2004 (N = 6277) | 2005–2009 (N = 8965) | 2010–2014 (N = 11,992) | 2015–2019 (N = 11,950) | Total (N = 39,184) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | n | % | |
| Risk Factors | 1576 | 25.11 | 1918 | 21.39 | 2530 | 21.10 | 2498 | 20.90 | 8522 | 21.75 |
| Incidence | 1199 | 19.10 | 1412 | 15.75 | 1794 | 14.96 | 1876 | 15.70 | 6281 | 16.03 |
| Prevalence | 1068 | 17.01 | 1510 | 16.84 | 1853 | 15.45 | 1704 | 14.26 | 6135 | 15.66 |
| Disease Outbreaks | 461 | 7.34 | 861 | 9.60 | 920 | 7.67 | 877 | 7.34 | 3119 | 7.96 |
| Risk Assessment | 342 | 5.45 | 664 | 7.41 | 710 | 5.92 | 776 | 6.49 | 2492 | 6.36 |
| Registries | 425 | 6.77 | 464 | 5.18 | 615 | 5.13 | 827 | 6.92 | 2331 | 5.95 |
| Sex Distribution | 634 | 10.10 | 496 | 5.53 | 485 | 4.04 | 319 | 2.67 | 1934 | 4.94 |
| Sex Factors | 218 | 3.47 | 343 | 3.83 | 470 | 3.92 | 328 | 2.74 | 1359 | 3.47 |
| Hospitalization | 203 | 3.23 | 214 | 2.39 | 401 | 3.34 | 447 | 3.74 | 1265 | 3.23 |
| Comorbidity | 186 | 2.96 | 192 | 2.14 | 343 | 2.86 | 500 | 4.18 | 1221 | 3.12 |
| Health Surveys | 192 | 3.06 | 275 | 3.07 | 453 | 3.78 | 267 | 2.23 | 1187 | 3.03 |
| Public Health | 182 | 2.90 | 300 | 3.35 | 359 | 2.99 | 334 | 2.79 | 1175 | 3.00 |
| Treatment Outcome | 150 | 2.39 | 265 | 2.96 | 343 | 2.86 | 390 | 3.26 | 1148 | 2.93 |
| Sensitivity and Specificity | 265 | 4.22 | 321 | 3.58 | 297 | 2.48 | 213 | 1.78 | 1096 | 2.80 |
| Survival Rate | 127 | 2.02 | 191 | 2.13 | 305 | 2.54 | 360 | 3.01 | 983 | 2.51 |
| Severity of Illness Index | 238 | 3.79 | 297 | 3.31 | 234 | 1.95 | 203 | 1.70 | 972 | 2.48 |
| Cause of Death | 185 | 2.95 | 183 | 2.04 | 304 | 2.54 | 295 | 2.47 | 967 | 2.47 |
| Vaccination | 109 | 1.74 | 137 | 1.53 | 249 | 2.08 | 438 | 3.67 | 933 | 2.38 |
| Disease Notification | 194 | 3.09 | 251 | 2.80 | 257 | 2.14 | 226 | 1.89 | 928 | 2.37 |
| Health Status | 182 | 2.90 | 212 | 2.36 | 277 | 2.31 | 142 | 1.19 | 813 | 2.07 |